JNJ
Johnson & Johnson
155.63
USD
This page is just a preview of the data found in TrendSpider’s full version
Johnson & Johnson stock is up 3.13% since 30 days ago. The next earnings date is Jan 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 07 Dec 15:51 | 17 Jan, 2025 | 165.00 | 2134 | ||
| 07 Dec 15:59 | 19 Jan, 2024 | 155.00 | 8617 | ||
| 07 Dec 16:08 | 17 Jan, 2025 | 165.00 | 2134 | ||
| 07 Dec 16:09 | 17 Jan, 2025 | 165.00 | 2134 | ||
| 07 Dec 18:18 | 19 Jan, 2024 | 160.00 | 16186 | ||
| 07 Dec 19:40 | 19 Jan, 2024 | 160.00 | 16186 | ||
| 07 Dec 19:41 | 19 Jan, 2024 | 160.00 | 16186 | ||
| 07 Dec 19:47 | 21 Jun, 2024 | 160.00 | 4503 | ||
| 07 Dec 19:54 | 17 Jan, 2025 | 165.00 | 2134 | ||
| 07 Dec 20:09 | 19 Jan, 2024 | 160.00 | 16186 |
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands. Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. MedTech segment provides electrophysiology products to treat cardiovascular diseases.
